Tia A. Abbas
PhD student, Imperial College London, Department of Bioengineering.
MSci in Biochemistry, and MSc in Infection and Immunity obtained from King’s College London and University College London, respectively.
Tia’s project focuses on engineering a tool to target senescent cells for the purpose of regressing the ageing phenotype. This translational medicine could potentially be applied to the treatment of several age-related disorders, i.e. Cancer, Auto-immune diseases, Type 2 Diabetes, and Cardiovascular Disease.